M B Youdim1, D Ben-Shachar, G Eshel, J P Finberg, P Riederer. Show Affiliations » 1. Department of Pharmacology, Technion-Bruce Rappaport Faculty of Medicine, Haifa, Israel.
Abstract
Entities: Chemical Disease
Mesh： See more » AnimalsDeferoxamine/pharmacologyDominance, Cerebral/drug effectsDominance, Cerebral/physiologyFerritins/metabolismFree RadicalsHumansHydrogen Peroxide/metabolismHydroxides/metabolismHydroxyl RadicalInjections, IntraventricularIron/metabolismIron/toxicityLipid Peroxidation/drug effectsLipid Peroxidation/physiologyNitric Oxide/metabolismNitric Oxide/toxicityOxidopamine/toxicityParkinson Disease/etiologyParkinson Disease/physiopathologyParkinson Disease, Secondary/chemically inducedParkinson Disease, Secondary/physiopathologyRatsStereotyped Behavior/drug effectsStereotyped Behavior/physiologySubstantia Nigra/drug effectsSubstantia Nigra/physiopathology
Substances： See more » Free RadicalsHydroxidesNitric OxideHydroxyl RadicalOxidopamineFerritinsHydrogen PeroxideIronDeferoxamine
Year: 1993 PMID： 8380520
Source DB: PubMed Journal: Adv Neurol ISSN： 0091-3952